Drug companies continue to raise list prices. Photo: Joe Raedle / Getty Images

A handful of drug companies rang in 2018 with price hikes that easily surpass inflation but stay conspicuously below double digits. Investment banks Jefferies and Cowen highlighted some of the big ones (listed below the fold).

Get smart: Our reporting might sound like a broken record, but it's the truth: Despite public outcry, the pharmaceutical industry has no incentive to change its drug pricing tactics.

Some of the drug companies raising prices:

  • AbbVie's blockbuster Humira: 9.7%
  • Amgen's arthritis medicine Enbrel: 9.7%
  • Allergan's dry eye drug Restasis: 9.5%
  • Insys Therapeutics' opioid spray Subsys: 9.5%
  • Biogen's multiple sclerosis drug Tecfidera: 8%

But wait, there's more: Cowen conducted a survey of large drug purchasers, and most said drug prices will continue to rise. More than three-quarters of respondents also said there's almost no chance U.S. drug price controls will occur in the next three years.

Go deeper

Felix Salmon, author of Capital
Updated 25 mins ago - Economy & Business

Trump risk rises for companies

Illustration: Aïda Amer/Axios

Donald Trump fancies himself a businessman — and has given himself a central role in determining the conduct and even the existence of major companies both domestic and foreign.

Why it matters: America has historically been a great place to operate a company under the rule of law, and not be beholden to political whim. Those days seem to be over — at least for companies in the communications industry.

Ben Geman, author of Generate
Updated 25 mins ago - Energy & Environment

China's split personality on climate

Illustration: Sarah Grillo/Axios

A new insta-analysis of China's vow to achieve "carbon neutrality" before 2060 helps to underscore why Tuesday's announcement sent shockwaves through the climate and energy world.

Why it matters: Per the Climate Action Tracker, a research group, following through would lower projected global warming 0.2 to 0.3°C. That's a lot!

Kayleigh McEnany: Trump will accept "free and fair" election, no answer on if he loses

White House press secretary Kayleigh McEnany said Thursday that President Trump will "accept the results of a free and fair election," but did not specify whether he will commit to a peaceful transfer of power if he loses to Joe Biden.

Why it matters: Trump refused to say on Wednesday whether he would commit to a peaceful transition of power, instead remarking: "we're going to have to see what happens."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!